EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Sustainable Innovation in Biopharma: Aligning Therapeutic Progress with Environmental Responsibility
To genuinely align RD with environmental responsibility biopharma organisations must embrace systemic structural and cultural transformations
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
ABM Pharma Tactics US: Unlocking B2B Lead Gen Success
US pharmaceutical market is highly competitive and regulated industry in the globe With the changing paradigm in commercialization and an increased complexity in buyer committees the traditional methods of demand generation are inadequate to support steady increase General campaigns that previously produced high volumes of inquiries are no longer able to provide highintent opportunity In this scen...
-
Techno Trends
Case Western Reserve Scientists Discover Novel Molecular Target for Parkinson’s Disease
Researchers at Case Western Reserve University have discovered a new biochemical pathway that could lead to treatments targeting the underlying causes of Parkinsons disease
-
Projects
PharmaEssentia Invests $46M to Expand U.S. Manufacturing Footprint for BESREMi®
PharmaEssentia Corporation has announced plans to establish a new wholly owned manufacturing subsidiary in Puerto Rico The US million investment aims to expand the production of BESREMi
-
Research Insights
Disproportionality analysis of drug-associated progressive multifocal leukoencephalopathy using spontaneous reports: A 20-year signal detection study based on the FAERS database
Progressive multifocal leukoencephalopathy PML is a rare often fatal demyelinating disease caused by JC virus reactivation in immunocompromised patients With the increasing use of immunosuppressants and biologics
-
White Papers
Accelerating In-Vitro Antibody Discovery with Artificial Intelligence
Antibodies have transformed modern medicine reshaping treatment paradigms across autoimmune disorders oncology and infectious diseases As one of the most versatile and successful therapeutic modalities
TOP ARTICLES
-
1
The Future of Pharma: Integrating Imaging Informatics for Better Outcomes
Kate Williamson
Imaging informatics revolutionizes the pharmaceutical industry by integrating advanced imaging techniques with data analytics to enhance drug discovery, personalize treatments, and improve patient out...
-
2
Advances in mRNA Therapeutics and Vaccines
Prince Kumar Lat
The ability to precisely target specific cells and deliver therapeutic payloads to their “site-of- action” has made mRNA a particularly attractive approach for personalized medicine. Recen...
-
3
Innovative Technologies Driving Vaccine Research and Production: A Revolution in Healthcare
Kate Williamson
“Innovative Technologies Driving Vaccine Research and Production" explores cutting-edge advancements such as mRNA vaccines, nanotechnology, AI-driven design, and blockchain-enabled supply c...
-
4
Advanced Hot Melt Extrusion: Pioneering Techniques in Pharmaceutical Formulation
Kate Williamson
Hot Melt Extrusion (HME) in pharmaceuticals has revolutionized drug delivery by enhancing solubility, controlling release profiles, and enabling combination therapies. Advanced techniques like twin-sc...
-
5
Regulatory Affairs Outsourcing: Benefits, Challenges, and Best Practices
Kate Williamson
A major transformation of regulatory compliance to pharma, biotech, and medical device firms is the outsourcing of regulatory activities to meet their needs through the availability of specialized kno...
press releasesRead more...
Affinia Therapeutics Granted FDA Fast Track Designation for AFTX-201 as a Treatment for People Living with BAG3-Associated Dilated Cardiomyopathy (DCM)
Affinia Therapeutics Affinia an innovative gene therapy company with a pipeline of firstinclass andor bestinclass adenoassociated virus AAV gene therapies initially for devastating cardiovascular diseases
Vasomune Therapeutics, Inc., and AnGes, Inc., Announce US FDA Clearance of Investigational New Drug (IND) Application For Pegevongitide (AV-001) Treatment in Resuscitation of Severely Burned Patients
Vasomune Therapeutics Inc a clinicalstage biopharmaceutical company today announced US Food and Drug Administration FDA clearance of the Investigational New Drug IND application to develop Pegevongitide AV
Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug
Teva Pharmaceuticals a US affiliate of Teva Pharmaceutical Industries Ltd NYSE and TASE TEVA and funds managed by Blackstone Life Sciences BXLS today announced a million strategic funding
Congruence and Ono Pharma Expand Multi-Target Research Partnership with the Addition of Two New Programs
Ono Pharmaceutical Co Ltd and Congruence Therapeutics today announced that they have expanded their existing multitarget research partnership through the execution of a new research collaboration for two additional programs
Events Read more...
05 - 06
Mar 2026ImmunoMark Summit 2026
DoubleTree by Hilton London | Tower of London, UK
09 - 11
Mar 20268th International Conference
8105, Suite 112, Rasor Blvd, Plano TX 75024, USA
10 - 12
Mar 2026Bioprocessing Summit Europe 2026
InterContinental Barcelona, Spain
10 - 10
Mar 2026Age of AI Europe 2026
Institute of Engineering and Technology (IET) London,UK
10 - 12
Mar 2026Healthcare & Hospi.Log Asia 2026
Singapore
11 - 12
Mar 20269th Annual Pharma Regulatory Summit 2026
Mumbai, India
16 - 17
Mar 2026Pharma USA 2026
Philadelphia, PA , USA
16 - 18
Mar 2026Pharmaceutics and Novel Drug
Kuala Lumpur, Malaysia
LATEST NEWSRead more...
INOVIO and Akeso Collaborate to Study New Combination Therapy for Glioblastoma
INOVIO and Akeso Inc have entered into a clinical trial collaboration and supply agreement to evaluate a new combination therapy for the treatment of Glioblastoma GBM an aggressive form of brain cancer
Sinopia Biosciences to Collaborate with Ono Pharmaceutical on Target Discovery for Rare Metabolic Disorders
Sinopia Biosciences Inc has announced a target discovery collaboration with Ono Pharmaceutical Co Ltd focused on a group of rare metabolic disorders The disorders remain undisclosed and are associated with significant unmet medical need
Vanda Receives FDA Grant for Formal Hearing on HETLIOZ® Application
Vanda Pharmaceuticals Inc has announced that the US Food and Drug Administration FDA has granted its request for a formal evidentiary public hearing regarding the proposed refusal to approve its supplemental
FDA Greenlights Boehringer Ingelheim's HERNEXEOS for HER2-Mutant NSCLC
The US FDA has approved Boehringer Ingelheims HERNEXEOS zongertinib tablets as the first targeted initial therapy for adults with advanced nonsmall cell lung cancer harboring HER ERBB tyrosine kinase domain activating mutations
PharmaEssentia Secures Japan Approval for High-Dose BESREMi® Regimen
PharmaEssentia Corporation has received approval in Japan for a highdose dosing regimen of BESREMi ropeginterferon alfab The approval was granted by Japans Ministry of Health Labour and Welfare and allows the updated dosing schedule to be included in the product label as an alternative option
Ono Pharma Expands Drug Discovery Collaboration with Congruence Therapeutics into Neurology and Immunology
Ono Pharmaceutical Co Ltd has expanded its drug discovery partnership with Congruence Therapeutics to include new programmes in neurology and immunology
